Adnkronos "Respiratory syncytial virus is a disease that should not be underestimated. The hope is that a vaccine available today, already evaluated for years, with absolutely negligible side effects and a remarkable multi-year coverage, will be included in the National Vaccination Prevention Plan (NPV)." This was stated by Fabrizio Pregliasco, director of the School of Specialization in Hygiene and Preventive Medicine at the University of Milan and Medical Director of the IRCCS Galeazzi Sant'Ambrogio Hospital in Milan, at a press conference organized by GSK during International Respiratory Syncytial Virus Awareness Week (2-8 November).
https://www.youtube.com/watch?v=1quH6HQOogQ
Continue on the app
The news of your city, in real time.
Open in app